Impact of contemporary emergency percutaneous coronary angioplasty for acute myocardial infarction on length of hospital stay

Swiss Medical Weekly

Volumn 137, Issue 25-26, 2007, Pages 363-367

  Schaer, Beat A ^a   Osswald, S ^a   Zellweger, M J ^a   Jegge, S ^a   Sticherling, C ^a   Pfisterer, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Acute myocardial infarction; Discharge; Emergency percutaneous coronary intervention; Hospital stay; Outcome; Risk assessment

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 34447294813     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349-60.
2. Naegeli B, Bertel O, Urban P, Angehrn W, Siegrist P, Stauffer JC, et al. Acute myocardial infarct in Switzerland: results from the PIMICS Heart Infarct Register. Schweiz Med Wochenschr. 1998;128:729-36.
3. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ. 1991;302:555-60.
4. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1999;341:1413-9.
5. Berger AK, Schulman KA, Gersh BJ, Pirzada S, Breall JA, Johnson AE, et al. Primary coronary angioplasty vs. thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA. 1999;282:341-8.
6. Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med. 2000;343:385-91.
7. De Luca G, Suryapranata H, van't Hof AW, de Boer MJ, Hoorntje JC, Dambrink JH, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004;109: 2737-43.
8. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999; 341:1882-90.
9. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al.; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83.
10. Jenni D, Osterwalder R, Osswald S, Buser P, Pfisterer M. Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998. Schweiz Rundsch Med Prax. 2001;90: 1759-65.
11. Heggunje PS, Harjai KJ, Stone GW, Mehta RH, Marsalese DL, Boura JA, et al. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1400-7.
12. Grines CL, Marsalese DL, Brodie B, Griffin J, Donohue B, Costantini CR, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol. 1998;31: 967-72.
13. Bogaty P, Dumont S, O'Hara GE, Boyer L, Auclair L, Jobin J, et al. Randomized trial of a non-invasive strategy to reduce hospital stay for patients with low-risk myocardial infarction. J Am Coll Cardiol. 2001;37:1289-96.
14. Kandzari DE, Tcheng JE, Cohen DJ, Bakhai A, Grines CL, Cox DA, et al. CADILLAC Investigators. Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial). Am J Cardiol. 2003;92:779-84.
15. Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH, et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol. 1996;27:625-32.
16. Brener SJ, Barr LA, Burchenal JE, Katz S, George BS, Jones AA, et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Circulation. 1998;98:734-41.
17. Newby LK, Eisenstein EL, Califf RM, Thompson TD, Nelson CL, Peterson ED, et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med. 2000;342:749-55.
18. Topol EJ, Burek K, O'Neill WW, Kewman DG, Kander NH, Shea MJ, et al. A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med. 1988;318:1083-8.
19. Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol. 1995;14:388-98.
20. Kinjo K, Sato H, Sakata Y, Nakatani D, Mizuno H, Shimizu M, et al. on Behalf of the Osaka Acute Coronary Insufficiency Study (OACIS) Group. Identification of uncomplicated patients with acute myocardial infarction undergoing percutaneous coronary intervention: are these patients suitable for early discharge? Circ J. 2005;69:1163-9.